The use of transient elastography in the management of chronic hepatitis B

Hepatology International

Volumn 5, Issue 4, 2011, Pages 868-875

  Fung, James ^a   Lai, Ching Lung ^a   Seto, Wai Kay ^a   Yuen, Man Fung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Fibroscan; Liver fibrosis; Noninvasive

Indexed keywords

ANTIVIRUS AGENT; ENTECAVIR;

ANTIVIRAL THERAPY; CLASSIFICATION ALGORITHM; CLINICAL ASSESSMENT; DIAGNOSTIC TEST; DIGESTIVE TRACT PARAMETERS; DISEASE ASSOCIATION; DRUG EFFICACY; ELASTOGRAPHY; FATTY LIVER; HEPATITIS B; HUMAN; INFLAMMATION; LIVER FIBROSIS; LIVER STIFFNESS; PATIENT MONITORING; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 81855183204     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-011-9288-5     Document Type: Review

References (69)

1. CL Lai V Ratziu MF Yuen, et al. 2003 Viral hepatitis B Lancet 362 2089 2094 14697813 10.1016/S0140-6736(03)15108-2 1:CAS:528:DC%2BD3sXpvFylsb4%3D (Pubitemid 38032767)
2. W Lee 1997 Hepatitis B virus infection N Engl J Med 337 1733 1745 9392700 10.1056/NEJM199712113372406 1:STN:280:DyaK1c%2FktFyjtA%3D%3D (Pubitemid 27527771)
3. L Pagliaro F Rinaldi A Craxi, et al. 1983 Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis: a prospective, randomized trial Dig Dis Sci 28 39 43 6217961 10.1007/BF01393359 1:STN:280:DyaL3s7gsVKntQ%3D%3D (Pubitemid 13223401)
4. B Maharaj RJ Maharaj WP Leary, et al. 1986 Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver Lancet 1 523 525 2869260 10.1016/S0140-6736(86)90883-4 1:STN:280: DyaL287ksFynsw%3D%3D (Pubitemid 16138427)
5. AA Bravo SG Sheth S Chopra 2001 Liver biopsy N Engl J Med 344 495 500 11172192 10.1056/NEJM200102153440706 1:STN:280:DC%2BD3M7ksVehtw%3D%3D (Pubitemid 32164902)
6. KD Lindor C Bru RA Jorgensen, et al. 1996 The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy Hepatology 23 1079 1083 8621137 10.1002/hep.510230522 1:STN:280:DyaK283gs1GgtA%3D%3D (Pubitemid 26137050)
7. J Perrault DB McGill BJ Ott, et al. 1978 Liver biopsy: complications in 1,000 inpatients and outpatients Gastroenterology 74 103 106 618417 1:STN:280:DyaE1c%2FksVajsA%3D%3D (Pubitemid 8248893)
8. M Fraquelli C Rigamonti G Casazza, et al. 2007 Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease Gut 56 7 968 973 17255218 10.1136/gut.2006.111302 (Pubitemid 46999083)
9. M Ziol A Handra-Luca A Kettaneh, et al. 2005 Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C Hepatology 41 48 54 15690481 10.1002/hep.20506 (Pubitemid 40066382)
10. L Castera J Vergniol J Foucher, et al. 2005 Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C Gastroenterology 128 343 350 15685546 10.1053/j.gastro.2004.11.018 (Pubitemid 40439195)
11. V de Ledinghen C Douvin A Kettaneh, et al. 2006 Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients J Acquir Immune Defic Syndr 41 175 179 16394849 10.1097/01.qai.0000194238.15831.c7
12. C Corpechot A El Naggar A Poujol-Robert, et al. 2006 Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC Hepatology 43 1118 1124 16628644 10.1002/hep.21151 (Pubitemid 43724636)
13. P Nahon A Kettaneh I Tengher-Barna, et al. 2008 Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease J Hepatol 49 1062 1068 18930329 10.1016/j.jhep.2008.08.011
14. VW Wong J Vergniol GL Wong, et al. 2010 Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease Hepatology 51 454 462 20101745 10.1002/hep.23312 1:CAS:528:DC%2BC3cXisVGgurk%3D
15. P Marcellin M Ziol P Bedossa, et al. 2009 Noninvasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B Liver Int 29 242 247 18637064 10.1111/j.1478-3231.2008.01802.x
16. HL Chan GL Wong PC Choi, et al. 2009 Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (fibroscan) for liver fibrosis in chronic hepatitis B J Viral Hepat 16 36 44 18673426 10.1111/j.1365-2893.2008.01037.x
17. M Friedrich-Rust MF Ong S Martens, et al. 2008 Performance of transient elastography for the staging of liver fibrosis: a meta-analysis Gastroenterology 134 960 974 18395077 10.1053/j.gastro.2008.01.034 (Pubitemid 351451980)
18. EA Tsochatzis KS Gurusamy S Ntaoula, et al. 2011 Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy J Hepatol 54 4 650 659 21146892 10.1016/j.jhep.2010.07.033 1:STN:280:DC%2BC3M3ns1KhtA%3D%3D
19. DY Kim SU Kim SH Ahn, et al. 2009 Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B Dig Dis Sci 54 1758 1763 19005758 10.1007/s10620-008-0541-2 1:CAS:528:DC%2BD1MXnvVais7w%3D
20. F Oliveri B Coco P Ciccorossi, et al. 2008 Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases World J Gastroenterol 14 6154 6162 18985805 10.3748/wjg.14.6154 1:CAS:528:DC%2BD1MXivVWnsr8%3D
21. D Roulot S Czernichow H Le Clesiau, et al. 2008 Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome J Hepatol 48 606 613 18222014 10.1016/j.jhep.2007.11.020
22. R Sirli I Sporea A Tudora, et al. 2009 Transient elastographic evaluation of subjects without known hepatic pathology: does age change the liver stiffness? J Gastrointestin Liver Dis 18 57 60 19337635
23. S Colombo L Belloli M Zaccanelli, et al. 2011 Normal liver stiffness and its determinants in healthy blood donors Dig Liver Dis 43 3 231 236 20817625 10.1016/j.dld.2010.07.008
24. SU Kim GH Choi WK Han, et al. 2010 What are 'true normal' liver stiffness values using FibroScan?: a prospective study in healthy living liver and kidney donors in South Korea Liver Int 30 268 274 19929903 10.1111/j.1478-3231.2009. 02172.x 1:CAS:528:DC%2BC3cXhslWhurk%3D
25. J Fung CL Lai SC Chan, et al. 2010 Correlation of liver stiffness and histological features in healthy persons and in patients with occult hepatitis B, chronic active hepatitis B, or hepatitis B cirrhosis Am J Gastroenterol 105 1116 1122 19920809 10.1038/ajg.2009.665
26. CL Lai MF Yuen 2007 The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points Ann Intern Med 147 58 61 17606962
27. T Andreani L Serfaty D Mohand, et al. 2007 Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome Clin Gastroenterol Hepatol 5 636 641 17428739 10.1016/j.cgh.2007.01.005 (Pubitemid 46660766)
28. M Kumar SK Sarin S Hissar, et al. 2008 Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT Gastroenterology 134 1376 1384 18471514 10.1053/j.gastro.2008.02.075 (Pubitemid 351615375)
29. PS Tsang H Trinh RT Garcia, et al. 2008 Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels Clin Gastroenterol Hepatol 6 569 574 18455697 10.1016/j.cgh.2008.02.037 (Pubitemid 351609458)
30. MH Nguyen RT Garcia HN Trinh, et al. 2009 Histological disease in Asian-Americans with chronic hepatitis B, high hepatitis B virus DNA, and normal alanine aminotransferase levels Am J Gastroenterol 104 2206 2213 19491836 10.1038/ajg.2009.248 1:CAS:528:DC%2BD1MXhtVOntb%2FF
31. CC Wang LY Lim H Deubner, et al. 2008 Factors predictive of significant hepatic fibrosis in adults with chronic hepatitis B and normal serum ALT J Clin Gastroenterol 42 820 826 18458642 10.1097/MCG.0b013e318156feef
32. WK Seto CL Lai J Fung, et al. 2010 HBV DNA levels predict significant liver histology for HBeAg-negative chronic hepatitis B patients Gastroenterology 138 S788 10.1016/S0016-5085(10)63629-3
33. HL Chan SW Tsang CT Liew, et al. 2002 Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection Am J Gastroenterol 97 406 412 11866280 10.1111/j.1572-0241.2002.05478.x 1:CAS:528:DC%2BD38XitVKnurc%3D (Pubitemid 34160768)
34. G Zacharakis J Koskinas S Kotsiou, et al. 2008 The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression: a prospective cohort study J Hepatol 49 884 891 18674840 10.1016/j.jhep.2008.06.009 1:CAS:528:DC%2BD1cXhtl2qu7bM
35. MF Yuen IO Ng ST Fan, et al. 2004 Significance of HBV DNA levels in liver histology of HBeAg and Anti-HBe positive patients with chronic hepatitis B Am J Gastroenterol 99 2032 2037 15447768 10.1111/j.1572-0241.2004.40440.x (Pubitemid 39421251)
36. JF Cadranel P Lahmek X Causse, et al. 2007 Epidemiology of chronic hepatitis B infection in France: risk factors for significant fibrosis-results of a nationwide survey Aliment Pharmacol Ther 26 565 576 17661760 10.1111/j.1365-2036.2007.03400.x (Pubitemid 47174285)
37. S Maimone V Calvaruso M Pleguezuelo, et al. 2009 An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers J Viral Hepat 16 769 774 19709363 10.1111/j.1365-2893.2009.01120.x 1:STN:280:DC%2BD1MnosleqtA%3D%3D
38. L Castera PH Bernard B Le Bail, et al. 2011 Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers Aliment Pharmacol Ther 33 455 465 21235598 10.1111/j.1365-2036.2010. 04547.x 1:STN:280:DC%2BC3M7hsl2isQ%3D%3D
39. YF Liaw N Leung JH Kao, et al. 2008 Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update Hepatol Int 3 263 283 10.1007/s12072-008-9080-3
40. AS Lok BJ McMahon 2009 Chronic hepatitis B: update 2009 Hepatology 50 661 662 19714720 10.1002/hep.23190
41. SJ Hadziyannis NC Tassopoulos EJ Heathcote, et al. 2006 Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years Gastroenterology 131 1743 1751 17087951 10.1053/j.gastro.2006.09.020 1:CAS:528:DC%2BD2sXhtFyltLs%3D (Pubitemid 44958517)
42. Chang TT, Liaw YF, Wu SS, et al. (2010) Long-term entecavir therapy results in reversal of fibrosis/cirrhosis and continued histologic improvement in chronic hepatitis B patients. Hepatology 2010;52(3):886-893
43. M Enomoto M Mori T Ogawa, et al. 2010 Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: Regression of liver stiffness during entecavir therapy Hepatol Res 40 853 861 20887589 10.1111/j.1872-034X.2010.00687.x 1:CAS:528:DC%2BC3cXhtlSgt7jP
44. R Masuzaki R Tateishi H Yoshida, et al. 2009 Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography Hepatology 49 1954 1961 19434742 10.1002/hep.22870
45. Fung J, Lai CL, Seto WK, et al. (2010) Prognostic significance of liver stiffness for hepatocellular carcinoma and mortality in HBeAg-negative chronic hepatitis B. J Viral Hepat 2011;18:e200-e205
46. KS Jung SU Kim SH Ahn, et al. 2011 Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan) Hepatology 53 885 894 21319193 10.1002/hep.24121 1:CAS:528:DC%2BC3MXkt1Clt78%3D
47. L Castera B Le Bail F Roudot-Thoraval, et al. 2009 Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores J Hepatol 50 59 68 19013661 10.1016/j.jhep.2008.08.018
48. F Kazemi A Kettaneh G N'Kontchou, et al. 2006 Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices J Hepatol 45 230 235 16797100 10.1016/j.jhep.2006.04.006
49. F Vizzutti U Arena RG Romanelli, et al. 2007 Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis Hepatology 45 1290 1297 17464971 10.1002/hep.21665 (Pubitemid 46775793)
50. C Bureau S Metivier JM Peron, et al. 2008 Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease Aliment Pharmacol Ther 27 1261 1268 18397389 10.1111/j.1365-2036.2008.03701.x 1:CAS:528:DC%2BD1cXotlCktbs%3D (Pubitemid 351697282)
51. J Fung CL Lai DY Fong, et al. 2008 Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis Liver Int 28 1408 1416 18482268 10.1111/j.1478-3231.2008. 01784.x
52. B Coco F Oliveri AM Maina, et al. 2007 Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases J Viral Hepat 14 360 369 17439526 10.1111/j.1365-2893.2006.00811.x 1:STN:280:DC%2BD2s3jtFamtQ%3D%3D (Pubitemid 46587854)
53. U Arena F Vizzutti G Corti, et al. 2008 Acute viral hepatitis increases liver stiffness values measured by transient elastography Hepatology 47 380 384 18095306 10.1002/hep.22007 1:CAS:528:DC%2BD1cXitF2ltb0%3D (Pubitemid 351280705)
54. A Sagir A Erhardt M Schmitt, et al. 2008 Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage Hepatology 47 592 595 18098325 10.1002/hep.22056 1:CAS:528:DC%2BD1cXitF2lu74%3D (Pubitemid 351280727)
55. GL Wong VW Wong PC Choi, et al. 2009 Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B J Gastroenterol Hepatol 24 1002 1007 19457152 10.1111/j.1440-1746. 2009.05779.x
56. J Fung CL Lai D But, et al. 2010 Reduction of liver stiffness following resolution of acute flares of chronic hepatitis B Hepatol Int 4 4 716 722 21286342 10.1007/s12072-010-9189-z
57. J Fung CL Lai C Cheng, et al. 2011 Mild-to-moderate elevation of alanine aminotransferase increases liver stiffness measurement by transient elastography in patients with chronic hepatitis B Am J Gastroenterol 106 3 492 496 21157442 10.1038/ajg.2010.463 1:CAS:528:DC%2BC3MXislOls70%3D
58. GL Wong VW Wong PC Choi, et al. 2009 Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B Gut 58 111 117 18832522 10.1136/gut.2008.157735
59. M Yoneda M Yoneda H Mawatari, et al. 2008 Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD) Dig Liver Dis 40 371 378 18083083 10.1016/j.dld.2007.10.019 1:CAS:528:DC%2BD1cXns1yhsLc%3D
60. S Gaia S Carenzi AL Barilli, et al. 2011 Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis J Hepatol 54 64 71 20932598 10.1016/j.jhep.2010.06. 022
61. GL Wong VW Wong PC Choi, et al. 2010 Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B Aliment Pharmacol Ther 31 1095 1103 20180785 10.1111/j.1365-2036.2010.04276.x
62. BK Kim KH Han JY Park, et al. 2010 A novel liver stiffness measurement-based prediction model for cirrhosis in hepatitis B patients Liver Int 30 1073 1081 20492510 10.1111/j.1478-3231.2010.02269.x 1:CAS:528: DC%2BC3cXhtVGksr3O
63. HJ Lee YS Seo DJ Kim, et al. 2011 Application of the HALF index obviates the need for liver biopsy in half of all patients with chronic hepatitis B J Gastroenterol Hepatol 26 6 987 995 21198828 10.1111/j.1440-1746.2010.06609.x 1:CAS:528:DC%2BC3MXotFymt7o%3D
64. RP Myers P Crotty G Pomier-Layrargues, et al. 2010 Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy Liver Int 30 1471 1480 20807336 10.1111/j.1478-3231.2010.02331. x
65. SU Kim YS Seo JY Cheong, et al. 2010 Factors that affect the diagnostic accuracy of liver fibrosis measurement by Fibroscan in patients with chronic hepatitis B Aliment Pharmacol Ther 32 498 505 20491742 10.1111/j.1365-2036.2010. 04353.x 1:CAS:528:DC%2BC3MXhtFChsL0%3D
66. J Foucher L Castera PH Bernard, et al. 2006 Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations Eur J Gastroenterol Hepatol 18 411 412 16538113 10.1097/00042737-200604000-00015
67. L Castera J Foucher PH Bernard, et al. 2010 Pitfalls of liver stiffness measurement: a 5-year prospective study of 13, 369 examinations Hepatology 51 828 835 20063276
68. M Pinzani F Vizzutti U Arena, et al. 2008 Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography Nat Clin Pract Gastroenterol Hepatol 5 95 106 18253138 10.1038/ncpgasthep1025 1:CAS:528:DC%2BD1cXhs1Ojtb8%3D (Pubitemid 351234279)
69. NH Afdhal M Curry 2007 Technology evaluation: a critical step in the clinical utilization of novel diagnostic tests for liver fibrosis J Hepatol 46 543 545 17316879 10.1016/j.jhep.2007.01.008 (Pubitemid 46400150)